Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) Non Operating Income (2018 - 2025)

Catheter Precision (VTAK) has disclosed Non Operating Income for 8 consecutive years, with -$5000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Non Operating Income fell 66.67% to -$5000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$4.0 million, a 44.67% increase, with the full-year FY2024 number at -$2.3 million, down 28137.5% from a year prior.
  • Non Operating Income was -$5000.0 for Q3 2025 at Catheter Precision, up from -$1.7 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $4.7 million in Q2 2023 to a low of -$5.6 million in Q4 2023.
  • A 5-year average of -$258941.2 and a median of -$3000.0 in 2024 define the central range for Non Operating Income.
  • Biggest YoY gain for Non Operating Income was 39333.33% in 2023; the steepest drop was 9637.29% in 2023.
  • Catheter Precision's Non Operating Income stood at -$19000.0 in 2021, then surged by 410.53% to $59000.0 in 2022, then crashed by 9637.29% to -$5.6 million in 2023, then soared by 59.98% to -$2.3 million in 2024, then surged by 99.78% to -$5000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Non Operating Income are -$5000.0 (Q3 2025), -$1.7 million (Q2 2025), and -$2.3 million (Q4 2024).